Medicine and Dentistry
Testis Cancer
83%
Programmed Cell Death
62%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
55%
Colorectal Tumor
50%
Childhood Cancer
50%
Prevalence
45%
Plasminogen Activator Inhibitor-1
40%
Adenoma
39%
Hereditary Nonpolyposis Colorectal Cancer
38%
DNA Polymorphism
36%
Soft Tissue Sarcoma
36%
Colon
35%
Beta-Catenin
35%
Radiation Therapy
35%
Neoplasm
34%
ABC Transporter Subfamily B
33%
Isotopes of Calcium
33%
Metabolic Syndrome
33%
Familial Adenomatous Polyposis
29%
Single Nucleotide Polymorphism
29%
Germ Cell Cancer
27%
Blood Vessel Injury
26%
Multidrug Resistance Associated Protein
25%
Dysplasia
25%
Placebo
24%
Cardiovascular Risk
23%
Lung Resistance Protein
22%
Cisplatin
22%
Death Receptor
21%
Colorectal Adenoma
21%
Intima-Media Thickness
21%
Downregulation
21%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
19%
Cardiovascular System
19%
Colon Cancer
19%
Epithelial Cell
18%
Death Receptor 4
18%
Adenoma Cell Line
17%
Diastolic Dysfunction
16%
Randomized Controlled Trial
16%
Catenin
16%
Steroid 5alpha Reductase
16%
Steroid 5alpha Reductase 2
16%
Finger Dermatoglyphics
16%
Bleomycin Hydrolase
16%
Systolic Dysfunction
16%
Metastatic Carcinoma
16%
Receptor Expression
16%
Hemicolectomy
16%
Cell Proliferation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Testis Cancer
100%
Chemotherapy
86%
Cisplatin
57%
Neoplasm
38%
Plasminogen Activator Inhibitor 1
33%
Hereditary Nonpolyposis Colorectal Cancer
33%
Long Term Exposure
33%
Placebo
22%
Adenoma
21%
Cardiovascular Risk
18%
Prevalence
17%
Beta Catenin
16%
Childhood Cancer
16%
Diastolic Dysfunction
16%
Colon Cancer
16%
Fas Ligand
16%
Sulindac
16%
Familial Adenomatous Polyposis
16%
Colorectal Tumor
16%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
16%
Bleomycin
16%
Lung Toxicity
16%
Metallothionein
16%
Systolic Dysfunction
16%
Pheochromocytoma
16%
Sennoside
16%
Catecholamine
16%
Carcinoid
16%
Germ Cell Tumor
16%
Randomized Controlled Trial
16%
Laxative
16%
Hypogonadism
15%
Paresthesia
13%
Venous Thromboembolism
12%
Ischemic Heart Disease
12%
Protein P53
12%
Germ Cell Cancer
10%
Cancer Classification
10%
Disease
10%
Metabolic Syndrome X
10%
Overall Survival
9%
Colorectal Cancer
9%
Carcinogenesis
8%
Pharmacokinetics
8%
Disease Free Survival
8%
Melanosis
8%
Triacylglycerol
6%
Malignant Neoplasm
5%
Levamisole
5%
Blood Vessel Injury
5%
Keyphrases
Chemotherapy
43%
Testicular Cancer
40%
Testicular Cancer Survivors
27%
Cardiovascular Risk
23%
Cancer Patients
22%
Nonseminomatous Testicular Cancer
16%
Postradiation Sarcoma
16%
Plasminogen Activator inhibitor-1 (PAI-1)
16%
Catecholamine-synthesizing Enzyme
16%
Cisplatin Sensitivity
16%
Metallothionein
16%
Vascular Damage
16%
Gene Polymorphism
16%
Vascular Events
16%
Damage Markers
16%
Metastatic Progression
16%
5α-reductase Type 2 Deficiency
16%
5α-reductase
16%
Vascular Toxicity
16%
Right Hemicolectomy
16%
Childhood Cancer Survivors
16%
Telomere Length
16%
Telomere Shortening
13%
Cisplatin-based Chemotherapy
11%
Genotype
11%
Metabolic Syndrome
10%
Hypogonadism
10%
Coronary Artery Disease
8%
Melanosis Coli
8%
Poor Prognosis
8%
Venous Thromboembolism
8%
Cardiovascular Status
8%
Voltammetric Method
8%
Cardiovascular Markers
8%
Germ Cell Tumor
8%
Cancer Classification
8%
PAI-1 4G/5G Polymorphism
8%
Cardiovascular Events
7%
Angiosarcoma
7%
Arterial Events
7%
Von Willebrand Factor
7%
Homozygous Variant
6%
Diastolic Blood Pressure
6%
Short Telomere
6%
Dopamine β-hydroxylase
6%
Cumulative Cisplatin Dose
5%
Platinol
5%
KIT Gene
5%
High Prevalence
5%
Early Relapse
5%
